Hematology/Oncology

Top Story

Trial to assess feasibility, safety of CAR T-cell therapy for relapsed pediatric central nervous system tumors

Trial to assess feasibility, safety of CAR T-cell therapy for relapsed pediatric central nervous system tumors
July 20, 2018
FDA News

FDA approves Nivestym, biosimilar to Neupogen, for treatment of neutropenia

July 20, 2018
The FDA approved the biosimilar filgrastim-aafi, designed to promote white blood cell recovery among individuals who have undergone treatments that can trigger…
In the Journals Plus

Robotic-assisted cystectomy noninferior to open procedure

July 20, 2018
Robotic-assisted cystectomy demonstrated comparable 2-year PFS to open cystectomy among patients with bladder cancer, according to phase 3 results from the RAZOR trial…
Meeting News

Keys to selecting the right telehealth platform

July 20, 2018
WASHINGTON — Whether for real-time e-visits or remote patient monitoring, telehealth is likely to play a big role in the future of medicine as more technology and…
In the Journals Plus

HPV-related oropharyngeal cancer incidence increasing among older adults

July 20, 2018
The median age of patients with HPV-related oropharyngeal squamous cell carcinoma increased since 1995, reflecting the increasing incidence among older adults, according…
More Headlines »
CME CPE CNE

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Video
Meeting News

VIDEO: Bayer executive highlights ASCO data in breast cancer, urothelial carcinoma, glioblastoma

June 21, 2018
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting

CME

Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Current Issues
View the Current Issue
HemOnc Today